KR870002019B1 - Process for preparation of amine derivatives - Google Patents
Process for preparation of amine derivatives Download PDFInfo
- Publication number
- KR870002019B1 KR870002019B1 KR1019850004197A KR850004197A KR870002019B1 KR 870002019 B1 KR870002019 B1 KR 870002019B1 KR 1019850004197 A KR1019850004197 A KR 1019850004197A KR 850004197 A KR850004197 A KR 850004197A KR 870002019 B1 KR870002019 B1 KR 870002019B1
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- formula
- compound
- nitromethane
- alkylating agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C331/00—Derivatives of thiocyanic acid or of isothiocyanic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
Abstract
Description
본 발명의 아민 유도체의 제조방법에 관한 것이다. N-메틸-1-알킬티오-2-니트로에텐아민 유도체는 니자티닌처럼-NHC(=CHNO2)NHCH3말단그룹을 함유하는 라니티딘 및 기타의 히스타민 H2-길항제를 제조하기 위한 중간체로서 유용하다.It relates to a process for preparing the amine derivative of the present invention. N-methyl-1-alkylthio-2-nitroethenamine derivatives are intermediates for the preparation of ranitidine and other histamine H 2 -antagonists containing -NHC (= CHNO 2 ) NHCH 3 end groups, such as nizatinine. useful.
이러한 중간체는 2,2-비스알킬티오-1-니트로에텐 유도체중의 단일 알킬티오 그룹을 메틸아민과 반응시켜 직접 치환시킴으로써 선행 기술에서 제조되어 왔다. 그러나, 이러한 반응은 선택성이 부족하여, 미 반응 출발물질과 비스-아민화된 부산물인 2,2-비스메틸아미노-1-니트로에텐으로 오염된 N-메틸-1-알킬티오-2-니트로에텐을 제공한다.Such intermediates have been prepared in the prior art by reacting a single alkylthio group in a 2,2-bisalkylthio-1-nitroethene derivative with methylamine to directly substitute it. However, this reaction lacks selectivity, resulting in N-methyl-1-alkylthio-2-nitro contaminated with unreacted starting material and 2,2-bismethylamino-1-nitroethene, a bis-amined byproduct. Provide ethene.
영국 특허명세서 제1421792호에는 다음의 반응도식에 따라 다음 일반식(A)의 화합물을 제조하는 방법이 기술되어 있다:British Patent 1414292 describes a process for preparing compounds of Formula (A) according to the following scheme:
상기의 반응도식에서,In the above scheme,
X 및 Y 는 동일하거나, 상이하며, 각각 수소, 나트로, 시아노 또는 SO2Ar(여기서,Ar은 임의로 치환된 페닐)이고 (단. X 및 Y 는 둘 다 수소일 수는 없다), R은 저급알킬이며, R2는 저급알킬 또는 아르알킬이다.X and Y are the same or different and each is hydrogen, natro, cyano or SO 2 Ar (where Ar is optionally substituted phenyl), provided that X and Y cannot both be hydrogen; Is lower alkyl and R 2 is lower alkyl or aralkyl.
치환된 메탄 CH2XY는 수소화나트륨 또는 수산화나트륨 등의 강염기화 반응시킨 후 이소티오시아네이트에스테르와 반응시킨다. 기술되어 있는 이 반응의 특정한 실시예에서는, 메틸 이소티오시아네이트는 수소화나트륨 및 디메틸포름아미드의 존재하에 말로노니트릴과 반응시킨다. 반응의 제 2단계는 디메틸포름아미드 중에서 메틸아이오다이드를 가하여 수행한다.Substituted methane CH 2 XY is reacted with isothiocyanate ester after strong base reaction such as sodium hydride or sodium hydroxide. In a particular embodiment of this reaction described, methyl isothiocyanate is reacted with malononitrile in the presence of sodium hydride and dimethylformamide. The second step of the reaction is carried out by adding methyl iodide in dimethylformamide.
문헌[Chem. Ber. 100, p591 내지 604(1967)]에는 페닐 이소티오시아네이트와 니트로메탄과의 반응이 기술되어 있으며, 또한 그 반응은 디메틸포름 아미드 중에서 수소화 나트륨의 존재하에 수행하여야만 한다고 기술되어 있다. 그 반응은 후속하여 메틸 아이오다이드로 메틸화되어 N-페닐-1-메틸티오-2-니트로에텐아민을 생성시킨다.Chem. Ber. 100, p591 to 604 (1967), describe the reaction of phenyl isothiocyanate with nitromethane, and that the reaction must also be carried out in the presence of sodium hydride in dimethylformamide. The reaction is subsequently methylated with methyl iodide to yield N-phenyl-1-methylthio-2-nitroethenamine.
상기의 참조 문헌에 교시되어 있는 바와 같이, 디메틸포름아미드 중의 수소화나트륨을 사용하는 것은 이들 시약을 혼합하는 것과 관련된 공지된 위험효소를 고려하여 보면 대규모의 제조에는 부적합하다.As taught in the above reference, the use of sodium hydride in dimethylformamide is unsuitable for large scale preparation in view of the known dangerous enzymes involved in mixing these reagents.
본 발명은, 용매로서 디메틸 설폭사이드의 존재하에, 임의로 보조용매의 존재하에, 메틸 이소티오시아네이트를 니트로메탄의 카바니온과 반응시킴을 특징으로 하는, 다음 일반식(Ⅰ)의 화합물의 제조방법을 제공한다.The present invention provides a process for preparing a compound of formula (I) wherein methyl isothiocyanate is reacted with carbanion of nitromethane in the presence of dimethyl sulfoxide as a solvent, optionally in the presence of a cosolvent. To provide.
통상적으로 카바니온은 적합한 염기와의 반응에 의해 니트로메탄으로부터 동일반응계 내에서 발생한다. 일반식(Ⅰ)의 화합물에서, Q는 니트로메탄의 카바니온을 생성시키기 위해 사용하는 염기로부터 유도된 양이온이다.Typically carbanion is generated in situ from nitromethane by reaction with a suitable base. In the compound of general formula (I), Q is a cation derived from the base used to produce the carbanion of nitromethane.
Q가 수소원자인 일반식(Ⅰ)의 화합물은 1당량의 적합한 산을 가하여 Q가 양이온인 일반식(Ⅰ)의 화합물로부터 제조할 수 있다.Compounds of formula (I) wherein Q is a hydrogen atom can be prepared from compounds of formula (I) wherein Q is a cation by adding one equivalent of a suitable acid.
Q가 수소 또는 양이온인 일반식(Ⅰ)의 화합물은 알킬 할라이드(예를들면, 메틸브로마이드 또는 메틸아이오다이드) 또는 디알킬 설페이트(예를 들면, 디메틸 설페이트)와 같은 적합한 알킬화제로 처리되어 다음 일반식(Ⅱ)의 N-메틸-1-알킬티오-2-니트로 에텐아민유도체를 생성시킨다.Compounds of formula (I) wherein Q is hydrogen or a cation are treated with a suitable alkylating agent such as alkyl halide (e.g., methyl bromide or methyliodide) or dialkyl sulfate (e.g., dimethyl sulfate) N-methyl-1-alkylthio-2-nitroethenamine derivative of formula (II) is produced.
상기식에서,In the above formula,
R1은 C1-4알킬그룹, 바람직하게는 메틸이다.R 1 is a C 1-4 alkyl group, preferably methyl.
메틸 이소티오시아네이트와 니트로메탄의 카바니온과의 반응을 용매로서 디메틸 설폭사이드 중에서, 임의로 보조용매의 존재하에 수행하는 경우,일반식(Ⅰ)의 화합물의 형성과 일반식(Ⅱ)의 N-메틸-1-알킬티오-2-니트로에텐아민 유도체의 생성이 특히 우수한 수율로 일어난다. 따라서, 염기로서 수소화나트륨 존재하에 메틸 이소티오시아네이트를 니트로메탄과 반응시킬 경우, 수율은 디메틸포름아미드를 용매로서 사용할 때의 22%에서 디메틸 설폭사이드를 용매에서 사용할 때의 59%로 증가한다.When the reaction of methyl isothiocyanate and nitromethane with carbanion is carried out in dimethyl sulfoxide as a solvent, optionally in the presence of a cosolvent, formation of a compound of formula (I) and N- of formula (II) The production of methyl-1-alkylthio-2-nitroethenamine derivatives takes place in particularly good yields. Thus, when methyl isothiocyanate is reacted with nitromethane in the presence of sodium hydride as the base, the yield increases from 22% when using dimethylformamide as solvent to 59% when using dimethyl sulfoxide in solvent.
바람직하게는, 일반식(Ⅰ)의 화합물은 동일 반응계 내에서 알킬화제와 반응시키며, 또 이 경우에 반응은 일반적으로 동일한 용매 매질 중에서 수행될 것이다.Preferably, the compound of formula (I) is reacted with an alkylating agent in situ, in which case the reaction will generally be carried out in the same solvent medium.
일반식(Ⅱ)의 N-메틸-1-알킬티오-2-니트로에텐-아민 유도체를 제조하기 위한 본 발명에 따르는 바람직한 방법은 메틸 이소티오시아네이트를 니트로메탄의 카바니온과 반응시켜 동일반응계 내에서 일반식(Ⅰ)의 화합물을 수득한 다음, 상기에서 언급한 바와 같이 적합한 알킬화제로 알킬화 시킴을 특징으로하며, 반응은 용매로서 디메틸 설폭사이드의 존재하에, 임의로 보조용매의 존재하에 수행한다. 사용하는 염기에 따라 선택하는 적합한 보조용매는 비양자성 용매(예를들면, 디메틸-포름아미드 및 N-메틸-피롤리돈) 및 물이다.A preferred process according to the invention for the preparation of N-methyl-1-alkylthio-2-nitroethene-amine derivatives of general formula (II) is to react methyl isothiocyanate with carbanion of nitromethane in situ. A compound of formula (I) is obtained in the interior, and then alkylated with a suitable alkylating agent as mentioned above, and the reaction is carried out in the presence of dimethyl sulfoxide as a solvent, optionally in the presence of a cosolvent. Suitable cosolvents to be selected depending on the base used are aprotic solvents (eg dimethyl-formamide and N-methyl-pyrrolidone) and water.
본 방법의 특정 실시양태는 메틸 아이오다이드 또는 디메틸 설페이트와 같은 적합한 메틸화제를 사용하여 동일반응계 내에서 제조한 일반식(Ⅰ)의 화합물을 메틸화시킴으로써 N-메틸-1-메틸티오-2-니트로에텐아민, 즉, R1이 메틸인 일반식(Ⅱ)의 화합물을 수득하는 것을 포함한다.Particular embodiments of the process include N-methyl-1-methylthio-2-nitro by methylating a compound of formula (I) prepared in situ using a suitable methylating agent such as methyl iodide or dimethyl sulfate. Etheneamine, ie, obtaining a compound of formula (II) wherein R 1 is methyl.
일반식(Ⅰ)의 화합물은 신규 화합물이다. 이들 화합물은 호변 이성체 형태로 존재할 수 있으며,일반식(Ⅰ) 은 이와같은 모든 형태를 포함한다. 본 발명은 Q가 수소 또는 알카리 금속양이온(특히, 나트륨 또는 칼륨)인 일반식(Ⅰ)의 화합물로 추가로 포함한다.The compound of general formula (I) is a novel compound. These compounds may exist in tautomeric forms, and general formula (I) includes all such forms. The present invention further encompasses as compounds of general formula (I) wherein Q is hydrogen or an alkali metal cation (particularly sodium or potassium).
본 발명의 방법은 일반식(Ⅱ)의 N-메틸-1-알킬티오-2-니트로에텐아민을, 더이상 정제하지 않고 라니티딘과 같은 화합물을 제조하는 데에 사용할 수 있는 형태로 제공하며 우수한 수율로 제공한다. 저렴하고, 간단하며, 시판되는 출발물질을 사용하는 본 방법은 일반적으로 대규모로 온화한 조건하에서 안전하게 수행할 수 있다. 특히, 본 발명의 방법은, N-메틸-1-메틸-티오-2-니트로에텐아민의 제조에 적용할 수 있다.The process of the present invention provides N-methyl-1-alkylthio-2-nitroethenamine of the general formula (II) in a form that can be used to prepare compounds such as ranitidine without further purification and with good yields. To provide. Inexpensive, simple and commercially available starting materials can generally be safely carried out under mild conditions on a large scale. In particular, the method of the present invention is applicable to the production of N-methyl-1-methyl-thio-2-nitroethenamine.
통상적으로 니트로메탄의 카바니온은 동일반응계 내에서 니트로메탄을 적당한 염기로 처리하여 제조한다. 특히 적합한 염기는 알카리 금속 수소화물, 알카리금속 수산화물 또는 알카리금속 알콕사이드를 포함하는데, 예를들면, 수소화나트륨, 수산화트륨, 나트륨 에톡사이드, 나트륨 이소프로폭사이드 및 칼륨 3급-부툭사이드가 있다. 알카리 금속 수산화물이 바람직하며, 염기가 알카리금속 수산화물일 경우에는 수용액으로서 가할 수 있다.Typically, the carbanion of nitromethane is prepared by treating nitromethane with a suitable base in situ. Particularly suitable bases include alkali metal hydrides, alkali metal hydroxides or alkali metal alkoxides, for example sodium hydride, sodium hydroxide, sodium ethoxide, sodium isopropoxide and potassium tert-butoxide. Alkali metal hydroxides are preferred, and when the base is an alkali metal hydroxide, it can be added as an aqueous solution.
동일 반응계 내에서 제조된 일반식(Ⅰ)의 화합물을 알킬화제와 계속 반응시킬 경우, 일반적으로 알킬화 반응을 위해 동일한 용매 매질이 사용될 것이다.If the compound of formula (I) prepared in situ is continuously reacted with an alkylating agent, the same solvent medium will generally be used for the alkylation reaction.
반응온도의 범위는 통상적으로 0 내지 50℃이며, 실온에서 반응을 행하는 것이 바람직하다.The range of reaction temperature is 0-50 degreeC normally, and it is preferable to carry out reaction at room temperature.
본 발명의 또다른 측면에 따라 본 발명은 상기에서 기술한 바와 같이 제조한 일반식(Ⅱ)의 N-메틸-1-알킬티오-2-니트로에텐아민 유도체를 적합한 아민과 반응시킴을 특징으로 하는-NHC(=CHNO2)NHCH3말단그룹을 함유하는 화합물, 특히 히스타민 H2길항제의 제조방법을 제공한다. 따라서, 본발명의 이러한 측면에 따라 아민으로서 2-[5-(N,N-디메틸아미노메틸)-2-푸란메틸티오]에틸아민으로부터, 바람직하게는 일반식(Ⅱ)의 화합물로서 N-메틸-1-메틸티오-2-니트로에텐아민을 사용하여 라니티닌을 제조할 수 있다. 반응은 물과 같은 용매 중에서, 임의로 가열하여 수행할 수 있다.According to another aspect of the invention, the present invention is characterized in that the N-methyl-1-alkylthio-2-nitroethenamine derivative of the general formula (II) prepared as described above is reacted with a suitable amine. Provided is a method for preparing a compound containing -NHC (= CHNO 2 ) NHCH 3 endgroup, in particular histamine H 2 antagonist. Thus, according to this aspect of the present invention from 2- [5- (N, N-dimethylaminomethyl) -2-furanmethylthio] ethylamine as amine, preferably N-methyl as compound of formula (II) Lanitinine can be prepared using -1-methylthio-2-nitroethenamine. The reaction can be carried out in a solvent such as water, optionally by heating.
다음의 실시예는 본 발명을 설명하지만, 본 발명을 한정하는 것은 아니다.The following examples illustrate the invention but do not limit the invention.
[실시예 1]Example 1
N-메틸-1-메틸티오-2-니트로에텐아민N-methyl-1-methylthio-2-nitroethenamine
(i) 디메틸 설폭사이드(물 7.5% 함유 : 18ml)중의 박편상 수산화칼륨(1.15g)의 현탁액에 니트로메탄(1.25g)을 1분간에 걸쳐 가한다. 20 내지 26℃를 유지하면서 디메틸 설폭사이드(물 7.5% 함유 : 2.5ml)중의 메틸 이소티오시아네이트(1.5g)의 용액을 2분간에 걸쳐 가한다. 실온에서 0.5시간 동안 용액을 교반한 다음 22 내지 24℃를 유지하면서 메틸 아이오다이드(3.19g)를 2분간에 걸쳐 적가한다. 실온에서 1시간동안 계속 교반한 다음 용액을 물(200ml)로 희석시키고, 디클로로메탄으로 추출한다. 혼합된 추출물을 물로 세척하고, 증발 건조시킨 다음, 잔류물을 2-프로판올로, 결정화하여 융점이 113 내지 116.5℃인 표제화합물(1.5g)을 49.4%의 수율로 수득한다.(i) Nitromethane (1.25 g) is added over 1 minute to a suspension of flaky potassium hydroxide (1.15 g) in dimethyl sulfoxide (7.5% water: 18 ml). A solution of methyl isothiocyanate (1.5 g) in dimethyl sulfoxide (containing 7.5% water: 2.5 ml) was added over 2 minutes while maintaining 20 to 26 ° C. After stirring the solution at room temperature for 0.5 hours, methyl iodide (3.19 g) is added dropwise over 2 minutes while maintaining 22-24 ° C. Stirring is continued for 1 hour at room temperature, then the solution is diluted with water (200 ml) and extracted with dichloromethane. The combined extracts are washed with water, evaporated to dryness and the residue is crystallized from 2-propanol to give the title compound (1.5 g) with a melting point of 113 to 116.5 ° C. in a yield of 49.4%.
(ii) 디메틸 설폭사이드(물 7.5% 함유 : 20ml) 중의 수소화나트륨(0.52g)에 디메틸 설폭사이드(물 7.5% 함유 :5ml)중의 니트로 메탄(1.32g)을 0 내지 5℃에서 5분간에 걸쳐 가한다. 혼합물을 실온까지 가온한 다음 30분 후에 디메틸 설폭사이드(물 7.5% 함유 :5ml)중의 메틸 이소티오시아네이트(1.58g)를 5분간에 걸쳐 가한다. 혼합물을 30℃이하로 유지하면서 디메틸 설폭사이드(물 7.5% 함유 :5ml)중의 메틸 아이오다이드(3.07g)로 처리한 다음 생성된 용액을 밤새 교반한다. 용매를 제거하고, 잔류물에 물(50ml)을 가한 다음, 실시예 1(i)의 과정에 따라 혼합물을 끝처리하여 융점이 112 내지 114℃인 표제화합물(1.88g)을 58.7%의 수율로 수득한다.(ii) Sodium hydride (0.52 g) in dimethyl sulfoxide (7.5% water: 20 ml) and nitromethane (1.32 g) in dimethyl sulfoxide (7.5% water: 5 ml) at 0-5 ° C. over 5 minutes. Add. The mixture is allowed to warm to room temperature and after 30 minutes methyl isothiocyanate (1.58 g) in dimethyl sulfoxide (7.5 ml water: 5 ml) is added over 5 minutes. The mixture is treated with methyl iodide (3.07 g) in dimethyl sulfoxide (5 ml containing 7.5% of water) while maintaining below 30 ° C. and the resulting solution is stirred overnight. The solvent was removed, water (50 ml) was added to the residue, and the mixture was finished following the procedure in Example 1 (i) to give the title compound (1.88 g) having a melting point of 112 to 114 ° C. in a yield of 58.7%. do.
(iii) 20 내지 25℃로 유지한 질소 대기하에서 무수디메틸 설폭사이드(9ml)중의 칼륨 3급-부톡사이드(1.1g)의 현탁액에 니트로메탄(0.62g)을 2분에 걸쳐 적가한다. 혼합물을 10분 동안 교반한 다음, 디메틸 설폭사이드(물 7.5% 함유:3ml)중의 메틸 이소티오시아네이트(0.715g)의 용액을 2분간에 걸쳐 적가한다. 실온에서 0.5시간 동안 계속 교반한 다음, 20 내지 25℃로 유지하면서 메틸아이오다이드(1.52g)를 2분간에 걸쳐 적가한다. 실온에서 2시간 동안 용액을 교반하고, 물(100ml)로 희석시킨 다음, 실시예 1(i)의 과정에 따라 끝처리하여 융점이 113 내지 115.5℃인 표제화합물(0.96g)을 66.1%의 수율로 수득한다.(iii) Nitromethane (0.62 g) was added dropwise over 2 minutes to a suspension of potassium tert-butoxide (1.1 g) in anhydrous dimethyl sulfoxide (9 ml) under a nitrogen atmosphere maintained at 20-25 ° C. The mixture is stirred for 10 minutes, then a solution of methyl isothiocyanate (0.715 g) in dimethyl sulfoxide (7.5% water: 3 ml) is added dropwise over 2 minutes. Stirring is continued at room temperature for 0.5 hours, and then methyl iodide (1.52 g) is added dropwise over 2 minutes while maintaining at 20-25 ° C. Stir the solution at room temperature for 2 hours, dilute with water (100 ml) and finish according to the procedure of Example 1 (i) to give the title compound (0.96 g) with a melting point of 113 to 115.5 ° C. in a yield of 66.1%. To obtain.
(iv) 실시예 1(iii)의 과정을 따르지만 칼륨 3급-부톡사이드 대신 수산화나트륨(1.6g)을 사용하고, 디메틸 설폭사이드(물 7.5% 함유: 35ml)중의 니트로메탄(2.44g) 및 디메틸 설폭사이드( 물 7.5% 함유 :5ml)중의 메틸 이소티오시아네이트(2.92g)를 사용하며 메틸 아이오다이드(6.25g)로 후속 알킬화시켜 융점이 113 내지 116℃인 표제화합물(2.64g)을 44.5%의 수율로 수득한다.(iv) Nitromethane (2.44 g) and dimethyl in dimethyl sulfoxide (7.5% water: 35 ml), following the procedure of Example 1 (iii) but using sodium hydroxide (1.6 g) instead of potassium tert-butoxide Subsequent alkylation with methyl iodide (6.25 g) using methyl isothiocyanate (2.92 g) in sulfoxide (7.5% water: 5 ml) afforded the title compound (2.64 g) having a melting point of 113 to 116 ° C. Obtained in% yield.
[실시예 2]Example 2
N-메틸-1-메틸티오-2-니트로에텐아민N-methyl-1-methylthio-2-nitroethenamine
물(12.4ml) 중의 수산화칼륨(20.88g)을 10 내지 15℃를 유지하면서, 디메틸 설폭사이드(185ml)중의 메틸 이소티오시아네이트(27.22g) 및 니트로메탄(22.75g)의 교반된 용액에 가한다. 10 내지 15℃에서 60분 동안 계속 교반한 다음 용액을 동일한 2획분(각각120ml)으로 나눈다.Potassium hydroxide (20.88 g) in water (12.4 ml) was added to a stirred solution of methyl isothiocyanate (27.22 g) and nitromethane (22.75 g) in dimethyl sulfoxide (185 ml) while maintaining 10 to 15 ° C. do. Stirring is continued at 10-15 ° C. for 60 minutes and then the solution is divided into two equal portions (120 ml each).
(i) 제 1 획분을, 디메틸 설페이트(17.62ml)를 15분간에 걸쳐 가하면서 10 내지 15℃에서 교반한다. 30분 동안 계속 교반한 다음, 물(90㎖)을 가하고 실시예 1(i)의 과정에 따라 끝처리하여 융점이 112.5 내지 114℃인 표제 화합물(12.45g)을 45.1%의 수율로 수득한다.(i) The first fraction is stirred at 10 to 15 ° C. while dimethyl sulfate (17.62 ml) is added over 15 minutes. Stirring was continued for 30 minutes, then water (90 mL) was added and finished according to the procedure of Example 1 (i) to give the title compound (12.45 g) with a melting point of 112.5 to 114 ° C. in a yield of 45.1%.
(ii) 제 2획분을 메틸 아이오다이드(11.66㎖)로 처리한 다음, 동일한 방법으로 끝처리하여 융점이 112.5 내지 114℃인 표제화합물(14.61g)을 52.9%의 수율로 수득한다.(ii) The second fraction was treated with methyl iodide (11.66 mL) and then finished in the same manner to give the title compound (14.61 g) having a melting point of 112.5 to 114 ° C. in a yield of 52.9%.
[실시예 3]Example 3
N-메틸-1-메틸티오-2-니트로에텐아민N-methyl-1-methylthio-2-nitroethenamine
무수 디메틸 설폭사이드(6.71g)중의 니트로메탄(1.05g) 및 에틸 이소티오시아네이트(1.26g)를 25℃이하로 유지하면서 디메틸포름아미드(4.3㎖) 중의 수소화나트륨(0.41g)의 교반된 현탁액에 70분간에 결쳐 가한다. 3시간 동안 계속 교반한 다음, 30℃이하로 유지하면서 메틸 아이오다이드(2.45g)를 15분간에 걸쳐 가한다. 생성된 용액을 30분 동안 교반하고, 물(9㎖)을 가한 다음,실시예 1(i)의 과정에 따라 용액을 끝처리하여 융점이 113.5 내지 115.5℃인 표제화합물(1.30g)을 50.8%의 수율로 수득한다.A stirred suspension of sodium hydride (0.41 g) in dimethylformamide (4.3 mL) while maintaining nitromethane (1.05 g) and ethyl isothiocyanate (1.26 g) in anhydrous dimethyl sulfoxide (6.71 g) below 25 ° C. Add in 70 minutes. Stirring is continued for 3 hours, and then methyl iodide (2.45 g) is added over 15 minutes while maintaining below 30 ° C. The resulting solution was stirred for 30 minutes, water (9 mL) was added, and the solution was finished according to the procedure of Example 1 (i) to give 50.8% of the title compound (1.30 g) having a melting point of 113.5 to 115.5 ° C. Obtained in yield.
[실시예 4]Example 4
N-메틸-1-메틸티오-2-니트로에텐아민N-methyl-1-methylthio-2-nitroethenamine
디메틸 설폭사이드(157.5㎖) 및 물(6.4㎖)중의 박편상 수산화칼륨(20.86g)의 현탁액에 니트로메틴(22.7g)을 15 내지 20℃를 유지하면서 8분간에 걸쳐 가한다. 디메틸 설폭사이드(27㎖) 및 물(1㎖) 중의 디메틸 이소티오시아네이트(27.19g)의 용액을 15 내지 25℃를 유지하면서 20분간에 걸쳐 적가한다. 실온에서 1시간 동안 더 교반한 다음 메틸 아이오다이드(52.78g)를 15 내지 20℃를 유지하면서 10분간에 걸쳐 가한다. 생성된 혼합물 실온에서 1시간동안 더 교반한 다음 물(178㎖)을 가하고, 실시예 1(i)의 과정에 따라 끝처리하여 융점이 113내지 116℃인 표제화합물(25.68g)을 46.6%의 수율로 수득한다.Nitromethine (22.7 g) was added to the suspension of flaky potassium hydroxide (20.86 g) in dimethyl sulfoxide (157.5 mL) and water (6.4 mL) over 8 minutes, maintaining 15-20 ° C. A solution of dimethyl sulfoxide (27 mL) and dimethyl isothiocyanate (27.19 g) in water (1 mL) was added dropwise over 20 minutes while maintaining 15-25 ° C. After further stirring at room temperature for 1 hour, methyl iodide (52.78 g) is added over 10 minutes while maintaining 15-20 ° C. The resulting mixture was further stirred for 1 hour at room temperature, followed by addition of water (178 mL), followed by the procedure of Example 1 (i) to give the title compound (25.68 g) having a melting point of 113 to 116 ° C. in a yield of 46.6%. Obtained as
[실시예 5]Example 5
N-[2-[5-(디메틸아미노)메틸-2-푸라닐메틸티오]에텔]-N´-메틸-2-니트로-1,1-에텐디아민N- [2- [5- (dimethylamino) methyl-2-furanylmethylthio] ether] -N'-methyl-2-nitro-1,1-ethenediamine
물(25ml)중의 2-[5-(N,N-디메틸아미노메틸)-2-푸란-메틸티오]에틸아민(32.1g)의 용액을 물(40ml)중의 N-메틸-1-메틸티오-2-니트로에텐아민(23g)의 교반된 용액에 50℃에서 4시간에 걸쳐 적가한다. 반응혼합물을 50℃에서 2시간 동안 더 가열한 다음 90℃까지 가열한다. 메틸 이소부틸케톤(150ml)을 용액에 가한 다음, 공비증류시켜 물을 제거한다. 용액을 60℃에서 냉각시키고 목탄(1.5g)을 가한다. 혼합물을 여과하고, 목탄잔류물을 메틸 이소부틸케톤(50㎖)으로 세척한 다음, 혼합된 여과액 및 세척물을 0℃까지 냉각시킨다. 융점이 68 내지 70℃인 표제화합물(39g)을 결정화시키고 여과한다.A solution of 2- [5- (N, N-dimethylaminomethyl) -2-furan-methylthio] ethylamine (32.1 g) in water (25 ml) was added with N-methyl-1-methylthio- in water (40 ml). To a stirred solution of 2-nitroethenamine (23 g) is added dropwise at 50 ° C. over 4 hours. The reaction mixture is further heated at 50 ° C. for 2 hours and then to 90 ° C. Methyl isobutyl ketone (150 ml) is added to the solution, followed by azeotropic distillation to remove the water. The solution is cooled at 60 ° C. and charcoal (1.5 g) is added. The mixture is filtered and the charcoal residue is washed with methyl isobutyl ketone (50 mL), then the mixed filtrate and wash are cooled to 0 ° C. The title compound (39 g) having a melting point of 68 to 70 DEG C is crystallized and filtered.
Claims (18)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB848415254A GB8415254D0 (en) | 1984-06-15 | 1984-06-15 | Amine derivatives |
GB8415254 | 1984-06-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR860000255A KR860000255A (en) | 1986-01-27 |
KR870002019B1 true KR870002019B1 (en) | 1987-11-30 |
Family
ID=10562466
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019850004197A KR870002019B1 (en) | 1984-06-15 | 1985-06-14 | Process for preparation of amine derivatives |
Country Status (22)
Country | Link |
---|---|
JP (2) | JPH0643382B2 (en) |
KR (1) | KR870002019B1 (en) |
AT (1) | AT395974B (en) |
BE (1) | BE902655A (en) |
CA (1) | CA1256454A (en) |
CH (1) | CH667871A5 (en) |
DE (1) | DE3521456A1 (en) |
DK (1) | DK170067B1 (en) |
ES (1) | ES8705359A1 (en) |
FI (1) | FI82239C (en) |
FR (1) | FR2565972B1 (en) |
GB (2) | GB8415254D0 (en) |
HU (1) | HU198179B (en) |
IE (1) | IE58606B1 (en) |
IL (1) | IL75523A (en) |
IT (1) | IT1209960B (en) |
NL (1) | NL8501727A (en) |
NO (1) | NO162461C (en) |
PT (1) | PT80643B (en) |
SE (1) | SE462913B (en) |
SG (1) | SG92590G (en) |
ZA (1) | ZA854502B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU9203905D0 (en) * | 1989-04-05 | 1993-04-28 | Glaxo Group Ltd | Method for producing ranitidine |
DE68910308D1 (en) * | 1989-05-10 | 1993-12-02 | Council Scient Ind Res | Process for the preparation of 1-amino-substituted 1-thio-substituted 2-nitro alkenes. |
US5686588A (en) * | 1995-08-16 | 1997-11-11 | Yoo; Seo Hong | Amine acid salt compounds and process for the production thereof |
YU52598A (en) * | 1998-11-19 | 2001-05-28 | D.D. Zdravlje- sektor za istraživanje i razvoj | Procedure for synthesis of n-[2[[[5-[ (dialkylamino)methyl] -2-furanil]methyl]thi0]etyl]-n'-alkyl-2-nitro 1,1 alkendiamine and its hydrochloride |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1421792A (en) * | 1973-05-17 | 1976-01-21 | Smith Kline French Lab | Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them |
GB1554153A (en) * | 1975-05-15 | 1979-10-17 | Smith Kline French Lab | Process for making 2-amino-2-alkylthionitroethylenes |
GB1565966A (en) | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
-
1984
- 1984-06-15 GB GB848415254A patent/GB8415254D0/en active Pending
-
1985
- 1985-06-13 IT IT8548213A patent/IT1209960B/en active
- 1985-06-14 FR FR858509049A patent/FR2565972B1/en not_active Expired
- 1985-06-14 IL IL75523A patent/IL75523A/en not_active IP Right Cessation
- 1985-06-14 HU HU852367A patent/HU198179B/en not_active IP Right Cessation
- 1985-06-14 CA CA000484041A patent/CA1256454A/en not_active Expired
- 1985-06-14 DK DK270585A patent/DK170067B1/en not_active IP Right Cessation
- 1985-06-14 BE BE0/215184A patent/BE902655A/en not_active IP Right Cessation
- 1985-06-14 AT AT0178085A patent/AT395974B/en active
- 1985-06-14 DE DE19853521456 patent/DE3521456A1/en active Granted
- 1985-06-14 FI FI852366A patent/FI82239C/en active IP Right Grant
- 1985-06-14 NO NO852418A patent/NO162461C/en not_active IP Right Cessation
- 1985-06-14 NL NL8501727A patent/NL8501727A/en not_active IP Right Cessation
- 1985-06-14 IE IE148485A patent/IE58606B1/en not_active IP Right Cessation
- 1985-06-14 ZA ZA854502A patent/ZA854502B/en unknown
- 1985-06-14 PT PT80643A patent/PT80643B/en not_active IP Right Cessation
- 1985-06-14 GB GB08515195A patent/GB2160204B/en not_active Expired
- 1985-06-14 SE SE8502973A patent/SE462913B/en not_active IP Right Cessation
- 1985-06-14 ES ES544214A patent/ES8705359A1/en not_active Expired
- 1985-06-14 KR KR1019850004197A patent/KR870002019B1/en not_active IP Right Cessation
- 1985-06-14 CH CH2530/85A patent/CH667871A5/en not_active IP Right Cessation
- 1985-06-15 JP JP60130673A patent/JPH0643382B2/en not_active Expired - Fee Related
-
1990
- 1990-11-13 SG SG925/90A patent/SG92590G/en unknown
-
1993
- 1993-09-16 JP JP5230589A patent/JPH06102656B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2176788C (en) | Process for producing 4-trifluoromethylnicotinic acid | |
RU2017728C1 (en) | Method of n-alkylated ureas synthesis | |
US4977264A (en) | Process for the production of 4,5-dichloro-6-ethylpyrimidine | |
KR870002019B1 (en) | Process for preparation of amine derivatives | |
US4131617A (en) | Preparation of new isobutylramide derivatives | |
US4212804A (en) | Process for the preparation of optionally substituted 2,3-indolinediones | |
WO1992015562A2 (en) | Preparation of omega-substituted alkanamide | |
KR910000239B1 (en) | Process for production of methyl 2-tetradecylgycidate | |
EP0242001B1 (en) | Process for the manufacture of n-(sulfonylmethyl) formamides and sulfonylmethylisocyanides | |
US4187225A (en) | Novel synthesis of bis pyrazolone oxonol dyes | |
US4261894A (en) | Process for the preparation of optionally substituted 2,3-indolinediones | |
FR2493316A1 (en) | NEW PROCESS FOR THE PREPARATION OF (TRIALCOXY BENZYL) -1 PIPERAZINES AND IN PARTICULAR (TRIMETHOXY-2 ', 3', 4 'BENZYL) -1 PIPERAZINE | |
KR930006198B1 (en) | Novel alpha-chloroketone derivative and process for preparation thereof | |
KR890000420B1 (en) | Preparation process for 4-benzoylpyrazol derivatives | |
FI90061B (en) | Process for the preparation of amine derivatives | |
KR950013852B1 (en) | Process for preparing 4-ethoxycarbonyl-1-methyl-5-pyrazole mercaptan | |
KR950013853B1 (en) | 4-process for preparing of 4-ethoxycarbonyl-1-methyl-5-pyrazole mercaptan | |
JP3012933B1 (en) | Dithianaphthalenophane compound and method for producing the same | |
JP3787866B2 (en) | Process for producing binuclear dimethylol compound of p-cresol | |
JP4663105B2 (en) | Method for producing 2-sulfonyl-4-oxypyridine derivative | |
KR810001319B1 (en) | Process for the preparation of new isobutyramide derivatives | |
KR880002619B1 (en) | Process for the preparation of metoprolol | |
KR910003636B1 (en) | Process for the preparation of benzophenon oxime compounds | |
JPH05286975A (en) | Production of 1-azabicyclo(3.3.0)octane derivative | |
KR950009482B1 (en) | Method for production of 2,5-dimethoxy-4-haloaniline |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
G160 | Decision to publish patent application | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20031030 Year of fee payment: 17 |
|
LAPS | Lapse due to unpaid annual fee |